Medtronic announces the 1st implantation in a U.S. investigational device exemption trial for its Evera SureScan MRI-safe implantable cardioverter-defibrillator.
Medtronic (NYSE:MDT) said the 1st patient was implanted with its MRI-safe Evera SureScan ICD as part of an investigational device exemption trial in the U.S.
Dr. George Bakris, co-principal investigator in Medtronic's Symplicity-3 trial, says renal denervation needs more study before attempting more clinical trials.
MASSDEVICE ON CALL — Dr. George Bakris, the co-principal investigator for Medtronic's (NYSE:MDT) failed Symplicty-3 renal denervation trial, believes further clinical work should be tabled until a few key questions about the therapy are answered.
A federal appeals court stays a ban on U.S. sales of Medtronic's CoreValve replacement heart valve "pending further notice" in a patent infringement battle with Edwards Lifesciences and its Sapien transcatheter aortic valve implant.
Edwards Lifesciences urges a federal appeals court to ignore Medtronic's alleged 'scare tactics' over a pending ban on its CoreValve replacement heart valve.
UPDATED April 21, 2014, at 12:30 p.m. with comment from Medtronic.
UPDATED April 21, 2014, at 3:45 p.m. with comment from Edwards Lifesciences.
Here's a look at some of the top legal news stories for medical device companies this week.
Medtronic touts positive data from a pair of clinical trials for its Endurant stent graft for treating abdominal aortic aneurysms.
Medtronic (NYSE:MDT) said data from a pair of clinical trials evaluating its Endurant stent graft for abdominal aortic aneurysms "affirm the Endurant stent graft's durable, consistent and proven outcomes."
A U.S. District Judge defends a ban on Medtronic's newly approved CoreValve transcatheter aortic valve implantation system, saying the company willfully ignored the law in bringing the device to the U.S. after it was found to infringe on a patent held by Edwards Lifesciences.
U.S. District Judge Gregory Sleet chided Medtronic (NYSE:MDT) this week after issuing a preliminary ban on the medtech titan's CoreValve transcatheter aortic valve implantation system.